Stay updated on ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial
Sign up to get notified when there's something new on the ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial page.

Latest updates to the ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial page
- Check6 days agoChange DetectedA notice about NIH website updates and the transition from “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov error page.SummaryDifference1%

- Check13 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check20 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content. The detailed ROSCO-CF study information and metadata are removed from view.SummaryDifference19%

- Check62 days agoChange DetectedRevision: v3.6.6 appears in the page's revision history, superseding v3.6.5. This update marks a new page revision in the site's maintenance log rather than a substantive change to trial data.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the page. This reflects a minor metadata update to the page’s version history and does not alter study content such as eligibility, locations, or outcomes.SummaryDifference0.0%

Stay in the know with updates to ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial page.